');//-->
McGraw-Hill Construction
SubscriptionsAdvertiseCareersContact UsMy AccountSign In
Visit Search
ENR.com
ENR Content Purchase Questions View Cart My ENR Content My ENR Account
ENR > Buildings > Pharmaceutical Firm Halts Half-Built, $400-Million Plant - McGraw-Hill Construction | ENR

This content is available for purchase and free of charge for ENR subscribers
Pharmaceutical Firm Halts Half-Built, $400-Million Plant - McGraw-Hill Construction | ENR

Publication Date: 22-JAN-07
Author:  Mary Buckner Powers
Price: $4.95
    Subscribe to ENR and get Access Full Article

Purchase Full ENR Article

Description
Pharmaceutical giant Eli Lilly and Co. has stopped construction on a half-built 300,000-sq-ft manufacturing plant in suburban Virginia as part of its effort to transform its operations to compete more effectively in the industry’s current business environment.

  Questions? Comments? Email Us


Generic Keywords: (What are these?)
Construction Industry, News Articles, Business Conditions & Analysis, Markets, Finance, Costs, Legislation, Government, Management, Labor, Construction Methods, Equipment & Materials, Engineering News-Record (ENR)

Annual Subscription
only $82
You will receive one full-year, 51 issues, which include 4 Sourcebooks and 2 double issues - along with 100% access to enr.com!

Monthly Subscription
only $9.95/month

Subscribe to ENR
 news
 Buildings
 Education
 Environment
 Finance and Business
 Power & Industrial
 Information Technology
 International
 Construction Technology
 Construction Week
 Transportation
 Safety & Health
 Washington Observer
 Work Place

 

© 2005 The McGraw-Hill Companies, Inc.
All Rights Reserved
Content Map